Cargo Therapeutics
(NASDAQ) CRGX
Cargo Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$7.83M
Net Income (TTM)
$221.78M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CRGX News
CRGX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cargo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
167
CEO
Anup Radhakrishnan
Website
www.cargo-tx.comHeadquarters
San Mateo, DE 94403, US
CRGX Financials
Key Financial Metrics (TTM)
Gross Margin
-63%
Operating Margin
-30%
Net Income Margin
-28%
Return on Equity
-69%
Return on Capital
-1%
Return on Assets
-86%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$7.07M
Operating Income
$187.37M
EBITDA
$160.43M
Operating Cash Flow
$139.74M
Capital Expenditure
$4.45M
Free Cash Flow
$144.19M
Cash & ST Invst.
$339.70M
Total Debt
$29.43M
Cargo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$572.00K
+72.2%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
167
N/A
Net Income
$49.94M
-12.6%
EBITDA
$15.23M
+64.0%
Quarterly Fundamentals
Net Cash
$251.99M
-39.3%
Accounts Receivable
$802.00K
-68.1%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$578.00K
-55.5%
Return on Assets
-85.76%
N/A
Return on Invested Capital
-1.00%
N/A
Free Cash Flow
$78.49M
-114.8%
Operating Cash Flow
$77.38M
-120.6%